↗3 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$317KSold on the market
1Companies
Sep 11, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 202619:45 | Sep 9, 2026 | ANTXAN2 Therapeutics, Inc. | Director | S · Sell10b5-1 | $6.02 | −1,108 | 624,765 | -0% | −$7K | ||
| Sep 8, 202619:42 | Sep 8, 2026from Sep 3, 2026 | ANTXAN2 Therapeutics, Inc. | Director | S · Sell10b5-1 | $6.04 | −16,119 | 625,350 | -3% | −$97K | ||
| Aug 19, 202617:58 | Aug 17, 2026 | ANTXAN2 Therapeutics, Inc. | Director | S · Sell10b5-1 | $6.01 | −35,402 | 633,867 | -5% | −$213K |